Open access
Open access
Powered by Google Translator Translator

Daily Archives: November 13, 2020

Covid-19: Inhaled Nebulized Interferon Beta-1a shows potential for hospitalized patients in preliminary trial

13 Nov, 2020 | 09:33h | UTC

Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial – The Lancet Respiratory Medicine

 


Preliminary study shows fluvoxamine may reduce clinical deterioration in outpatients with symptomatic COVID-19

13 Nov, 2020 | 09:35h | UTC

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial – JAMA

Editorial: COVID-19 Infection—Preventing Clinical Deterioration

Commentary: Fluvoxamine may prevent serious illness in COVID-19 patients, study suggests – Washington University School of Medicine

 


Long Covid: Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection

13 Nov, 2020 | 09:27h | UTC

Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection – PLOS One

Commentary: Half of recovered COVID-19 patients report lingering fatigue – CIDRAP

 


Long Covid: 2 months after being hospitalized for Covid-19, many patients persisted symptomatic and did not resume normal activities

13 Nov, 2020 | 09:28h | UTC

Sixty-Day Outcomes Among Patients Hospitalized With COVID-19 – Annals of Internal Medicine

Commentary: Life after COVID hospitalization: Study shows major lasting effects on health, work and more – University of Michigan

 

Commentary on Twitter

 


Case report: Persistence and evolution of SARS-CoV-2 in an immunocompromised host

13 Nov, 2020 | 09:24h | UTC

Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host – New England Journal of Medicine

 

Commentary on Twitter (thread – click for more)

 


How risky is air travel in the pandemic? Here’s what the science says

13 Nov, 2020 | 09:22h | UTC

How risky is air travel in the pandemic? Here’s what the science says – Vox

 


Tranexamic acid after traumatic brain injury: Exploratory analysis combining data from CRASH-2 and CRASH-3 trials suggests reduced mortality

13 Nov, 2020 | 09:21h | UTC

Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial – Critical Care

Commentary: New analysis combining data from the world’s largest trauma trials provides compelling evidence that rapid tranexamic acid treatment saves lives – London School of Hygiene & Tropical Medicine

 

Commentary on Twitter

 


Perspective: Many younger adults need to take Covid-19 more seriously as demographics shift

13 Nov, 2020 | 09:25h | UTC

Younger Adults Caught in COVID-19 Crosshairs as Demographics Shift – JAMA

 

Commentary from the author on Twitter (thread – click for more)

 


Mechanical ventilation in patients with acute brain injury: recommendations of the European Society of Intensive Care Medicine consensus

13 Nov, 2020 | 09:19h | UTC

Mechanical ventilation in patients with acute brain injury: recommendations of the European Society of Intensive Care Medicine consensus – Intensive Care Medicine

 


[Abstract Only] Study: An automated predictive model can identify hospitalized adults outside the ICU at risk for clinical deterioration for whom interventions by rapid-response teams could be implemented

13 Nov, 2020 | 09:16h | UTC

Automated Identification of Adults at Risk for In-Hospital Clinical Deterioration – New England Journal of Medicine (link to abstract – $ for full-text)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.